S Sousa A 1

1. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
2. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model
3. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air^® real-world data
4. Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference
5. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study
1